Correction: Increasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune recognition

Oncotarget. 2018 Aug 28;9(67):32881. doi: 10.18632/oncotarget.26079.

¹ Department of Immunology, Hospital Universitario Central de Asturias, Oviedo, Spain.
² Immunology Service, Instituto Murciano de Investigación Biosanitaria (IMIB), Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.
³ Department of Hematology, Hospital Universitario Central de Asturias, Oviedo, Spain.
⁴ Hematology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Department of Medicine, Universidad Complutense de Madrid (UCM), Madrid, Spain.
⁵ Hematology Service, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.
⁶ Hematology Service, Hospital General Universitario Santa Lucía, Cartagena, Murcia, Spain.

Abstract

[This corrects the article DOI: 10.18632/oncotarget.16657.].